Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.858 |
High Similarity |
NPD8150 |
Discontinued |
0.8382 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8101 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8101 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8101 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8079 |
Intermediate Similarity |
NPD6535 |
Approved |
0.8079 |
Intermediate Similarity |
NPD6534 |
Approved |
0.8024 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7977 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7977 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7964 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7955 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7944 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7944 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7927 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7923 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7901 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7892 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.788 |
Intermediate Similarity |
NPD8319 |
Approved |
0.788 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7857 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7857 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7857 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7857 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7857 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7857 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7857 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7821 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7821 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7821 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7784 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7758 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7756 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7707 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7707 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7707 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7702 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7672 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7672 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7657 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7634 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7634 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7634 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7619 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7602 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7594 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7594 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.759 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7586 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7566 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7546 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7543 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7543 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7529 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.746 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7458 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7456 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7455 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7452 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7448 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7444 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7416 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7407 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7396 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7396 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7384 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7362 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7358 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7326 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7293 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7262 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7239 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7232 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7229 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.72 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7169 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7167 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.716 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7135 |
Intermediate Similarity |
NPD37 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD1201 |
Approved |
0.711 |
Intermediate Similarity |
NPD4966 |
Approved |
0.711 |
Intermediate Similarity |
NPD4965 |
Approved |
0.711 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7101 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7099 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7091 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7086 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7083 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7067 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7063 |
Intermediate Similarity |
NPD943 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7055 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD920 |
Approved |
0.7019 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7017 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.6994 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6981 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6957 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.6947 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6942 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6942 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.694 |
Remote Similarity |
NPD5034 |
Approved |
0.694 |
Remote Similarity |
NPD4955 |
Approved |
0.694 |
Remote Similarity |
NPD5026 |
Approved |
0.694 |
Remote Similarity |
NPD4954 |
Approved |
0.694 |
Remote Similarity |
NPD5028 |
Approved |
0.694 |
Remote Similarity |
NPD36 |
Approved |
0.6937 |
Remote Similarity |
NPD7985 |
Registered |
0.6932 |
Remote Similarity |
NPD919 |
Approved |
0.6928 |
Remote Similarity |
NPD1243 |
Approved |
0.6923 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6914 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6898 |
Remote Similarity |
NPD8360 |
Approved |
0.6898 |
Remote Similarity |
NPD8361 |
Approved |
0.689 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6885 |
Remote Similarity |
NPD5030 |
Phase 2 |
0.6885 |
Remote Similarity |
NPD7240 |
Approved |
0.6882 |
Remote Similarity |
NPD5037 |
Approved |
0.6882 |
Remote Similarity |
NPD6273 |
Approved |
0.6882 |
Remote Similarity |
NPD5038 |
Approved |
0.6865 |
Remote Similarity |
NPD8407 |
Phase 2 |
0.6848 |
Remote Similarity |
NPD2438 |
Suspended |
0.6835 |
Remote Similarity |
NPD1164 |
Approved |
0.6832 |
Remote Similarity |
NPD411 |
Approved |
0.6828 |
Remote Similarity |
NPD5036 |
Approved |
0.6816 |
Remote Similarity |
NPD7930 |
Approved |
0.6813 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6813 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6811 |
Remote Similarity |
NPD5035 |
Approved |
0.6809 |
Remote Similarity |
NPD8435 |
Approved |
0.6807 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6807 |
Remote Similarity |
NPD2344 |
Approved |
0.6805 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6802 |
Remote Similarity |
NPD7584 |
Approved |
0.68
|
Remote Similarity |
NPD5760 |
Phase 2 |